CK

Chris Krueger

Chief Operating Officer

Endeavor BioMedicines

Encinitas, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Endeavor BioMedicines
Industry
biotechnology
Employees
48.0
Seniority
C suite
Annual Revenue
5000000.0
Total Funding
295583908.0
Latest Funding
Series C

Technologies

Outlook Amazon AWS BugHerd Nginx Mobile Friendly Facebook Custom Audiences Google Font API WordPress.org Google Tag Manager Facebook Login (Connect) Facebook Widget Gravity Forms Vimeo Typekit Remote AI

Keywords

clinical-stage fibrotic lung disease oncology transformational therapies env-101 hedgehog signaling pathway idiopathic pulmonary fibrosis env-501 antibody-drug conjugate her3-positive tumors clinical trials pipeline therapeutic development drug development life-threatening diseases cancer treatment disease-modifying therapies pulmonary fibrosis patient outcomes innovative medicines scientific research clinical benefits drug candidates patient lives biotech innovation cultural values healthcare collaborative research advanced therapies regulatory affairs therapeutic areas leadership clinical operations investigational therapies preclinical research therapeutic options investors strategic marketing biopharmaceuticals conversion therapy clinical data medical advisory publications transforming patient care healthcare equity cancer therapies specialized medicine scientific advisory board business development hospital & health care health care health wellness & fitness b2b

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans